Acute Coronary Syndrome: Reperfusion & Antithrombotics — free guideline decision tool
This tool gives the reperfusion or intervention timing and the antiplatelet/anticoagulation strategy for acute coronary syndrome, separating STEMI from NSTE-ACS.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Acute Coronary Syndrome: Reperfusion & Antithrombotics do?
Use to choose reperfusion in STEMI (primary PCI vs thrombolysis by time and feasibility) and intervention timing in NSTE-ACS by risk, with the antithrombotic backbone.
How is the result calculated?
STEMI: primary PCI if feasible ≤ 120 min, else thrombolysis within 12 h then transfer. NSTE-ACS: no thrombolysis, intervention by risk (very-high < 2 h, high < 24 h, intermediate < 72 h, low selective). DAPT (aspirin + ticagrelor) + parenteral anticoagulant ≥ 12 months.
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Acute Coronary Syndrome: Reperfusion & Antithrombotics now
This tool gives the reperfusion or intervention timing and the antiplatelet/anticoagulation strategy for acute coronary syndrome, separating STEMI from NSTE-ACS.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.